Zelluna ASA (OSL:ZLNA)

Norway flag Norway · Delayed Price · Currency is NOK
13.55
+0.05 (0.36%)
At close: Jul 11, 2025
-37.56%
Market Cap 277.15M
Revenue (ttm) 53.00K
Net Income (ttm) -100.73M
Shares Out 20.45M
EPS (ttm) -36.15
PE Ratio n/a
Forward PE n/a
Dividend n/a
Ex-Dividend Date n/a
Volume 4,701
Average Volume 8,376
Open 13.50
Previous Close 13.50
Day's Range 13.50 - 14.00
52-Week Range 12.00 - 22.50
Beta n/a
RSI 47.36
Earnings Date Aug 20, 2025

About Zelluna ASA

Zelluna ASA develops T-cell receptor (TCR) cellular immunotherapy products for the treatment of solid cancers. The company was founded in 2016 and is based in Oslo, Norway. [Read more]

Industry Biological Products, Except Diagnostic Substances
Founded 2016
Employees 22
Stock Exchange Oslo Børs
Ticker Symbol ZLNA
Full Company Profile

Financial Performance

Financial Statements

News

There is no news available yet.